{
  "DOI": "10.1038/s41431-022-01096-9",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-022-01096-9",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eWe examined how often genetic clinicians correctly identify psychosocial difficulties in women at high breast cancer risk and explored effects of this assessment and the genetic test result on counselees’ distress. A prospective observational study of counselee–clinician dyads was performed in three French, German and Spanish genetic clinics, involving 709 counselees (participation rate, 83.4%) and 31 clinicians (participation rate, 100%). Counselee–clinician agreement in perceived psychosocial difficulties was measured after the pre-test genetic consultation. Multivariate mixed linear models accounting for clinicians were tested. Predicted distress levels were assessed after the pre- (T1) and post-test result disclosure consultations (T2). Depending on the difficulty domain, clinicians adequately assessed the presence or absence of difficulties in 51% (“familial issues”) to 59% (“emotions”) of counselees. When counselees’ and clinicians’ perceptions disagreed, difficulties were generally underestimated by clinicians. Counselees’ distress levels remained stable from T1 to T2, irrespective of clinicians’ appraisal adequacy, and the genetic test result disclosure. Psychological referral need were found in 20–42% of counselees, more frequently observed for difficulties in the “emotions” domain. Our findings suggest that the genetic test result is a suboptimal indicator for psychological referral. Instead, clinicians should focus on emotions expressed by counselees to appraise their needs for psychological support.\u003c/jats:p\u003e",
  "alternative-id": [
    "1096"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "10 November 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "3 March 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "22 March 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "11 April 2022"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "DSL declares the following conflict of interest: AstraZeneca is funding the French COVAR study coordinated by the Institut Curie and aiming to the classification of \u003ci\u003eBRCA1/2\u003c/i\u003e Variants of Unknown Significance. The Department of Genetics of the Institut Curie is performing genotyping (PRS) of MammoRisk®, Predilife. DSL and the Institut Curie have received honorarium for her participation in education meetings organized by AstraZeneca or Tesaro®. RS declares the following conflict of interest: grants or contracts received from AstraZeneca, Amgen. Payment or honoraria received from AstraZeneca, JanssenCilag. Participation on an Advisory Board for AstraZeneca; MSD, GSK, Clovis Oncology. PD reports grants from EU Horizon 2020 program during the conduct of the study. All other authors declare no conflict of interest."
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The study protocol was approved in France by the Comité consultatif sur le traitement de l’information en matière de recherche dans le domaine de la santé (CCTIRS: Consultative committee for information management in health research—No. 16.314) and the Comité de Protection des Personnes Ile-de-France V (CPP—No. 18.12.28.38743 CAT2), in Germany by the Ethics Committee of the University Hospital of Cologne (No. 16-098) and in Spain by the Ethics Committee of the Instituto Catalán de Oncología of Barcelona (No. PR111/16). All recruited women provided written informed consent."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-1864-5371",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Brédart",
      "given": "Anne",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-6963-8411",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Kop",
      "given": "Jean-Luc",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-9985-8397",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Tüchler",
      "given": "Anja",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-3898-073X",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "De Pauw",
      "given": "Antoine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cano",
      "given": "Alejandra",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dick",
      "given": "Julia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rhiem",
      "given": "Kerstin",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-8023-2009",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Devilee",
      "given": "Peter",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Schmutzler",
      "given": "Rita",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5438-8309",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Stoppa-Lyonnet",
      "given": "Dominique",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dolbeault",
      "given": "Sylvie",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        4,
        11
      ]
    ],
    "date-time": "2022-04-11T02:02:38Z",
    "timestamp": 1649642558000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        9,
        1
      ]
    ],
    "date-time": "2022-09-01T23:04:36Z",
    "timestamp": 1662073476000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        4
      ]
    ],
    "date-time": "2024-03-04T15:22:44Z",
    "timestamp": 1709565764323
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "9",
  "issued": {
    "date-parts": [
      [
        2022,
        4,
        11
      ]
    ]
  },
  "journal-issue": {
    "issue": "9",
    "published-print": {
      "date-parts": [
        [
          2022,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            4,
            11
          ]
        ],
        "date-time": "2022-04-11T00:00:00Z",
        "timestamp": 1649635200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            4,
            11
          ]
        ],
        "date-time": "2022-04-11T00:00:00Z",
        "timestamp": 1649635200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-022-01096-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01096-9",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01096-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1067-1075",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2022,
        4,
        11
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        4,
        11
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJMoa1913948",
      "author": "L Dorling",
      "doi-asserted-by": "publisher",
      "first-page": "428",
      "journal-title": "N Engl J Med",
      "key": "1096_CR1",
      "unstructured": "Dorling L, Carvalho S, Allen J, González-Neira C, Luccarini C, Wahlström KA, et al. Breast cancer risk genes—association analysis in more than 113,000 women. N Engl J Med. 2021;384:428–39.",
      "volume": "384",
      "year": "2021"
    },
    {
      "DOI": "10.1002/pon.4686",
      "author": "I Esteban",
      "doi-asserted-by": "publisher",
      "first-page": "1530",
      "journal-title": "Psychooncology",
      "key": "1096_CR2",
      "unstructured": "Esteban I, Vilaro M, Adrover E, Angulo A, Carrasco E, Gadea N, et al. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psychooncology. 2018;27:1530–7.",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10897-014-9695-6",
      "author": "S Hiraki",
      "doi-asserted-by": "publisher",
      "first-page": "604",
      "journal-title": "J Genet Couns",
      "key": "1096_CR3",
      "unstructured": "Hiraki S, Rinella ES, Schnabel F, Oratz R, Ostrer H. Cancer risk assessment using genetic panel testing: considerations for clinical application. J Genet Couns. 2014;23:604–17.",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cncr.33357",
      "author": "JO Culver",
      "doi-asserted-by": "publisher",
      "first-page": "1275",
      "journal-title": "Cancer",
      "key": "1096_CR4",
      "unstructured": "Culver JO, Ricker CN, Bonner J, Kidd J, Sturgeon D, Hodan R, et al. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer. 2021;127:1275–85.",
      "volume": "127",
      "year": "2021"
    },
    {
      "DOI": "10.1002/pon.3485",
      "author": "W Eijzenga",
      "doi-asserted-by": "publisher",
      "first-page": "862",
      "journal-title": "Psychooncology",
      "key": "1096_CR5",
      "unstructured": "Eijzenga W, Bleiker EM, Hahn DE, Kluijt I, Sidharta GN, Gundy C, et al. Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics. Psychooncology. 2014;23:862–9.",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41431-018-0257-5",
      "author": "T Yanes",
      "doi-asserted-by": "publisher",
      "first-page": "28",
      "journal-title": "Eur J Hum Genet",
      "key": "1096_CR6",
      "unstructured": "Yanes T, Willis AM, Meiser B, Tucker KM, Best M. Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review. Eur J Hum Genet. 2019;27:28–35.",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1002/pon.933",
      "author": "B Meiser",
      "doi-asserted-by": "publisher",
      "first-page": "1060",
      "journal-title": "Psychooncology",
      "key": "1096_CR7",
      "unstructured": "Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology. 2005;14:1060–74.",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s12160-008-9060-9",
      "author": "TM Beran",
      "doi-asserted-by": "publisher",
      "first-page": "107",
      "journal-title": "Ann Behav Med",
      "key": "1096_CR8",
      "unstructured": "Beran TM, Stanton AL, Kwan L, Straatsma BR, Burgess BL. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Ann Behav Med. 2008;36:107–16.",
      "volume": "36",
      "year": "2008"
    },
    {
      "DOI": "10.1038/bjc.2012.599",
      "author": "A Bredart",
      "doi-asserted-by": "publisher",
      "first-page": "1012",
      "journal-title": "Br J Cancer",
      "key": "1096_CR9",
      "unstructured": "Bredart A, Kop JL, Depauw A, Caron O, Sultan S, Leblond D, et al. Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer. Br J Cancer. 2013;108:1012–20.",
      "volume": "108",
      "year": "2013"
    },
    {
      "DOI": "10.1038/s41431-018-0310-4",
      "author": "C Jacobs",
      "doi-asserted-by": "publisher",
      "first-page": "511",
      "journal-title": "Eur J Hum Genet.",
      "key": "1096_CR10",
      "unstructured": "Jacobs C, Patch C, Michie S. Communication about genetic testing with breast and ovarian cancer patients: a scoping review. Eur J Hum Genet. 2019;27:511–24.",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1002/pon.3920",
      "author": "P Butow",
      "doi-asserted-by": "publisher",
      "first-page": "987",
      "journal-title": "Psychooncology",
      "key": "1096_CR11",
      "unstructured": "Butow P, Price MA, Shaw JM, Turner J, Clayton JM, Grimison P, et al. Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines. Psychooncology. 2015;24:987–1001.",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10897-008-9173-0",
      "author": "B Meiser",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "journal-title": "J Genet Couns",
      "key": "1096_CR12",
      "unstructured": "Meiser B, Irle J, Lobb E, Barlow-Stewart K. Assessment of the content and process of genetic counseling: a critical review of empirical studies. J Genet Couns. 2008;17:434–51.",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1002/pon.3435",
      "author": "C Maheu",
      "doi-asserted-by": "publisher",
      "first-page": "420",
      "journal-title": "Psychooncology",
      "key": "1096_CR13",
      "unstructured": "Maheu C, Bouhnik AD, Nogues C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, et al. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure? Psychooncology. 2014;23:420–7.",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.2014.55.4576",
      "author": "W Eijzenga",
      "doi-asserted-by": "publisher",
      "first-page": "2998",
      "journal-title": "J Clin Oncol",
      "key": "1096_CR14",
      "unstructured": "Eijzenga W, Aaronson NK, Hahn DE, Sidharta GN, van der Kolk LE, Velthuizen ME, et al. Effect of routine assessment of specific psychosocial problems on personalized communication, counselors’ awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial. J Clin Oncol. 2014;32:2998–3004.",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.pec.2021.03.025",
      "author": "B Biesecker",
      "doi-asserted-by": "publisher",
      "first-page": "933",
      "journal-title": "Patient Educ Couns",
      "key": "1096_CR15",
      "unstructured": "Biesecker B, Lewis MA. Advancing genomic translation: Investigations in communication. A special series on communication research in the context of genomic medicine. Patient Educ Couns. 2021;104:933–4.",
      "volume": "104",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.pec.2013.05.004",
      "author": "RL Street Jr",
      "doi-asserted-by": "publisher",
      "first-page": "286",
      "journal-title": "Patient Educ Couns",
      "key": "1096_CR16",
      "unstructured": "Street RL Jr. How clinician-patient communication contributes to health improvement: modeling pathways from talk to outcome. Patient Educ Couns. 2013;92:286–91.",
      "volume": "92",
      "year": "2013"
    },
    {
      "DOI": "10.1136/bmjopen-2019-029926",
      "author": "A Bredart",
      "doi-asserted-by": "publisher",
      "first-page": "e029926",
      "journal-title": "BMJ Open",
      "key": "1096_CR17",
      "unstructured": "Bredart A, Kop JL, Dick J, Cano A, De Pauw A, Anota A, et al. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study. BMJ Open. 2019;9:e029926.",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.bulcan.2018.08.003",
      "author": "J Moretta",
      "doi-asserted-by": "publisher",
      "first-page": "907",
      "journal-title": "Bull Cancer",
      "key": "1096_CR18",
      "unstructured": "Moretta J, Berthet P, Bonadona V, Caron O, Cohen-Haguenauer O, Colas C, et al. [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]. Bull Cancer. 2018;105:907–17.",
      "volume": "105",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s12094-015-1435-3",
      "author": "G Llort",
      "doi-asserted-by": "publisher",
      "first-page": "956",
      "journal-title": "Clin Transl Oncol",
      "key": "1096_CR19",
      "unstructured": "Llort G, Chirivella I, Morales R, Ales-Martinez JE, Andres R, Balmana J, et al. SEOM clinical guidelines in Hereditary Breast and ovarian cancer. Clin Transl Oncol. 2015;17:956–61.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10549-019-05152-9",
      "author": "U Bick",
      "doi-asserted-by": "publisher",
      "first-page": "217",
      "journal-title": "Breast Cancer Res Treat",
      "key": "1096_CR20",
      "unstructured": "Bick U, Engel C, Krug B, Heindel W, Fallenberg EM, Rhiem K, et al. High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat. 2019;175:217–28.",
      "volume": "175",
      "year": "2019"
    },
    {
      "DOI": "10.1111/ecc.13173",
      "author": "A Bredart",
      "doi-asserted-by": "publisher",
      "first-page": "e13173",
      "journal-title": "Eur J Cancer Care",
      "key": "1096_CR21",
      "unstructured": "Bredart A, Anota A, Dick J, Cano A, De Pauw A, Kop JL, et al. The “Psychosocial Aspects in Hereditary Cancer” questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions. Eur J Cancer Care. 2020;29:e13173.",
      "volume": "29",
      "year": "2020"
    },
    {
      "DOI": "10.1192/bjp.156.1.79",
      "author": "D Razavi",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "journal-title": "Br J Psychiatry",
      "key": "1096_CR22",
      "unstructured": "Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry. 1990;156:79–83.",
      "volume": "156",
      "year": "1990"
    },
    {
      "key": "1096_CR23",
      "unstructured": "Herrmann-Lingen CBU, Snaith RP. HADS-D: Hospital Anxiety and Depression Scale—German; Manual. Bern: Hans Huber; 2011."
    },
    {
      "DOI": "10.1016/S0163-8343(03)00043-4",
      "author": "MJ Herrero",
      "doi-asserted-by": "publisher",
      "first-page": "277",
      "journal-title": "Gen Hospital Psychiatry",
      "key": "1096_CR24",
      "unstructured": "Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hospital Psychiatry. 2003;25:277–83.",
      "volume": "25",
      "year": "2003"
    },
    {
      "author": "AJ Viera",
      "first-page": "360",
      "journal-title": "Fam Med",
      "key": "1096_CR25",
      "unstructured": "Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.",
      "volume": "37",
      "year": "2005"
    },
    {
      "author": "S Gideon",
      "first-page": "461",
      "journal-title": "Ann Stat",
      "key": "1096_CR26",
      "unstructured": "Gideon S. Estimating the dimension of a model. Ann Stat. 1978;6:461–4.",
      "volume": "6",
      "year": "1978"
    },
    {
      "DOI": "10.1038/sj.bjc.6604952",
      "author": "S Singer",
      "doi-asserted-by": "publisher",
      "first-page": "908",
      "journal-title": "Br J Cancer",
      "key": "1096_CR27",
      "unstructured": "Singer S, Kuhnt S, Götze H, Hauss J, Hinz A, Liebm A, et al. Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer. 2009;100:908–12.",
      "volume": "100",
      "year": "2009"
    },
    {
      "DOI": "10.1002/(SICI)1097-0142(19981015)83:8\u003c1640::AID-CNCR21\u003e3.0.CO;2-#",
      "author": "S Newell",
      "doi-asserted-by": "publisher",
      "first-page": "1640",
      "journal-title": "Cancer",
      "key": "1096_CR28",
      "unstructured": "Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A. How well do medical oncologists’ perceptions reflect their patients’ reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer. 1998;83:1640–51.",
      "volume": "83",
      "year": "1998"
    },
    {
      "DOI": "10.1200/JCO.2011.35.9281",
      "author": "DW Shin",
      "doi-asserted-by": "publisher",
      "first-page": "4424",
      "journal-title": "J Clin Oncol",
      "key": "1096_CR29",
      "unstructured": "Shin DW, Kim SY, Cho J, Sanson-Fisher RW, Guallar E, Chai GY, et al. Discordance in perceived needs between patients and physicians in oncology practice: a nationwide survey in Korea. J Clin Oncol. 2011;29:4424–9.",
      "volume": "29",
      "year": "2011"
    },
    {
      "DOI": "10.1023/B:JOGC.0000044201.73103.4f",
      "author": "PN Butow",
      "doi-asserted-by": "publisher",
      "first-page": "403",
      "journal-title": "J Genet Couns",
      "key": "1096_CR30",
      "unstructured": "Butow PN, Lobb EA. Analyzing the process and content of genetic counseling in familial breast cancer consultations. J Genet Couns. 2004;13:403–24.",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1186/s40359-015-0063-6",
      "author": "L Gouveia",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Psychol",
      "key": "1096_CR31",
      "unstructured": "Gouveia L, Lelorain S, Bredart A, Dolbeault S, Bonnaud-Antignac A, Cousson-Gelie F, et al. Oncologists’ perception of depressive symptoms in patients with advanced cancer: accuracy and relational correlates. BMC Psychol. 2015;3:6.",
      "volume": "3",
      "year": "2015"
    },
    {
      "DOI": "10.1200/JCO.1998.16.4.1594",
      "author": "SD Passik",
      "doi-asserted-by": "publisher",
      "first-page": "1594",
      "journal-title": "J Clin Oncol",
      "key": "1096_CR32",
      "unstructured": "Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald D, Edgerton S. Oncologists’ recognition of depression in their patients with cancer. J Clin Oncol. 1998;16:1594–1600.",
      "volume": "16",
      "year": "1998"
    },
    {
      "DOI": "10.1016/j.pec.2011.04.017",
      "author": "J Vos",
      "doi-asserted-by": "publisher",
      "first-page": "239",
      "journal-title": "Patient Educ Couns",
      "key": "1096_CR33",
      "unstructured": "Vos J, Oosterwijk JC, Gomez-Garcia E, Menko FH, Collee MJ, van Asperen CJ, et al. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees’ perception matters, but the actual BRCA1/2 result does not. Patient Educ Couns. 2012;86:239–51.",
      "volume": "86",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s00520-019-04918-7",
      "author": "L Lombardi",
      "doi-asserted-by": "publisher",
      "first-page": "3647",
      "journal-title": "Support Care Cancer",
      "key": "1096_CR34",
      "unstructured": "Lombardi L, Bramanti SM, Babore A, Stuppia L, Trumello C, Antonucci I, et al. Psychological aspects, risk and protective factors related to BRCA genetic testing: a review of the literature. Support Care Cancer. 2019;27:3647–56.",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1034/j.1399-0004.2001.600501.x",
      "author": "BB Biesecker",
      "doi-asserted-by": "publisher",
      "first-page": "323",
      "journal-title": "Clin Genet",
      "key": "1096_CR35",
      "unstructured": "Biesecker BB. Goals of genetic counseling. Clin Genet. 2001;60:323–30.",
      "volume": "60",
      "year": "2001"
    },
    {
      "DOI": "10.1002/jgc4.1363",
      "author": "BB Biesecker",
      "doi-asserted-by": "publisher",
      "first-page": "42",
      "journal-title": "J Genet Couns",
      "key": "1096_CR36",
      "unstructured": "Biesecker BB, Lillie SE, Amendola LM, Donohue KE, East KM, Foreman AKM, et al. A review and definition of ‘usual care’ in genetic counseling trials to standardize use in research. J Genet Couns. 2021;30:42–50.",
      "volume": "30",
      "year": "2021"
    },
    {
      "DOI": "10.1177/1479973120933292",
      "author": "SC Wynne",
      "doi-asserted-by": "crossref",
      "first-page": "147997312093329",
      "journal-title": "Chronic Respiratory Dis",
      "key": "1096_CR37",
      "unstructured": "Wynne SC, Patel S, Barker RE, Jones SE, Walsh JA, Kon SS, et al. Anxiety and depression in bronchiectasis: Response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression Scale. Chronic Respiratory Dis. 2020;17:1479973120933292.",
      "volume": "17",
      "year": "2020"
    },
    {
      "DOI": "10.1054/bjoc.2000.1545",
      "author": "W Söllner",
      "doi-asserted-by": "publisher",
      "first-page": "179",
      "journal-title": "Br J Cancer",
      "key": "1096_CR38",
      "unstructured": "Söllner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer. 2001;84:179–85.",
      "volume": "84",
      "year": "2001"
    },
    {
      "DOI": "10.1038/s41431-020-00799-1",
      "author": "NM Medendorp",
      "doi-asserted-by": "publisher",
      "first-page": "789",
      "journal-title": "Eur J Hum Genet",
      "key": "1096_CR39",
      "unstructured": "Medendorp NM, Hillen MA, Visser LNC, Aalfs CM, Duijkers FAM, van Engelen K, et al. A randomized experimental study to test the effects of discussing uncertainty during cancer genetic counseling: different strategies, different outcomes? Eur J Hum Genet. 2021;29:789–99.",
      "volume": "29",
      "year": "2021"
    }
  ],
  "reference-count": 39,
  "references-count": 39,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-022-01096-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "30"
}